BioNexus Gene Lab (BGLC) Receivables - Other (2018 - 2025)
Historic Receivables - Other for BioNexus Gene Lab (BGLC) over the last 8 years, with Q3 2025 value amounting to $98903.0.
- BioNexus Gene Lab's Receivables - Other rose 5057.63% to $98903.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $98903.0, marking a year-over-year increase of 5057.63%. This contributed to the annual value of $203660.0 for FY2024, which is 6634.54% up from last year.
- As of Q3 2025, BioNexus Gene Lab's Receivables - Other stood at $98903.0, which was up 5057.63% from $151269.0 recorded in Q2 2025.
- BioNexus Gene Lab's 5-year Receivables - Other high stood at $400830.0 for Q2 2024, and its period low was $22933.0 during Q1 2021.
- For the 5-year period, BioNexus Gene Lab's Receivables - Other averaged around $104137.4, with its median value being $79517.0 (2021).
- In the last 5 years, BioNexus Gene Lab's Receivables - Other crashed by 6825.84% in 2022 and then skyrocketed by 74419.03% in 2024.
- Over the past 5 years, BioNexus Gene Lab's Receivables - Other (Quarter) stood at $79517.0 in 2021, then crashed by 68.26% to $25240.0 in 2022, then skyrocketed by 385.07% to $122432.0 in 2023, then soared by 66.35% to $203660.0 in 2024, then plummeted by 51.44% to $98903.0 in 2025.
- Its Receivables - Other stands at $98903.0 for Q3 2025, versus $151269.0 for Q2 2025 and $235727.0 for Q1 2025.